1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
    Broker Notes

    3 amazing ASX 200 shares to buy and hold forever

    | James Mickleboro

    Brokers think these shares are in the buy zone. Let's see why they could be top buy and hold picks.

    Read more »

    Shot of a scientist using a computer while conducting research in a laboratory.
    Healthcare Shares

    Should I buy the dip on CSL shares?

    | Bernd Struben

    A leading fund manager gives his verdict on the growth prospects for CSL shares.

    Read more »

    Cropped shot of an attractive young female scientist working on her computer in the laboratory.
    Healthcare Shares

    CSL shares among most expensive on ASX. Is now a good time to buy?

    | Samantha Menzies

    Analysts predict CSL share price growth will keep on coming.

    Read more »

    A young couple in the back of a convertible car each raise a single arm in the air whilst enjoying a drive along the road.
    Retirement

    How to invest your first $10,000 in ASX shares towards an early retirement

    | James Mickleboro

    Your first move could be an important one when it comes to building a retirement portfollio.

    Read more »

    A couple sit on the deck of a yacht with a beautiful mountain and lake backdrop enjoying the fruits of their long-term ASX shares and dividend income.
    Retirement

    How to retire early using ASX shares

    | James Mickleboro

    Want to retire early? Take a look at this guide.

    Read more »

    Happy woman working on a laptop.
    Broker Notes

    Macquarie's best ASX 200 share picks in each of the 11 market sectors

    | Bronwyn Allen

    Looking for stock-buying opportunities?

    Read more »

    A man and woman sit at a desk staring intently at a laptop screen with papers next to them.
    Share Market News

    ASX 200 ETF vs S&P 500: which has outperformed over 5 years

    | Aaron Bell

    Let’s compare the Aussie and US markets over the last 5 years based on the performance of these two ETFs

    Read more »

    A man in suit and tie is smug about his suitcase bursting with cash.
    Broker Notes

    These ASX 200 shares could rise 25% to 35%

    | James Mickleboro

    Analysts expect these shares to deliver big returns over the next 12 months.

    Read more »

    Broker written in white with a man drawing a yellow underline.
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's what brokers are recommending as buys this week.

    Read more »

    Woman in business suit holds both hands out with a question mark above each hand.
    Small Cap Shares

    Building a market beating portfolio: ASX 200 stocks vs small caps

    | Aaron Bell

    From blue-chip shares to small-caps what’s best for your portfolio?

    Read more »

    Health professional working on his laptop.
    Healthcare Shares

    Are CSL shares at risk from the Trump tariffs?

    | Bernd Struben

    How exposed are CSL shares to potential Trump medicinal tariffs?

    Read more »

    A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
    Blue Chip Shares

    If I were building a portfolio from scratch, I'd buy these 3 ASX 200 shares today

    | James Mickleboro

    These quality shares could be great picks for investors building a portfolio.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note